title: Reversal by the specific antidote, idarucizumab, of elevated dabigatran exposure in a patient with rectal perforation and paralytic ileus.
authors.affiliation: Pinneberg, Germany christian.thorborg@sana.de.
authors.forename: C
authors.initials: C
authors.lastname: Thorborg
authors.affiliation: Pinneberg, Germany.
authors.forename: E-P
authors.initials: EP
authors.lastname: Horn
authors.affiliation: Pinneberg, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Mofid
authors.affiliation: Hamburg, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Langer
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D000931:Antidotes / Q000494:pharmacology*; D000069604:Dabigatran / Q000009:adverse effects* / Q000097:blood; D005260:Female; D006801:Humans; D007416:Intestinal Perforation / Q000150:complications*; D007418:Intestinal Pseudo-Obstruction / Q000150:complications*; D012002:Rectal Diseases / Q000150:complications*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000931:Antidotes; C000594745:idarucizumab; D000069604:Dabigatran